AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Resmed DRC

39.810

+0.2900.73%

Volume:608.93K

Turnover:24.17M

Market Cap:58.28B

PE:2.91

High:39.810

Open:39.520

Low:39.370

Close:39.520

Loading ...

Overview Company News Filings

Jarden Adjusts ResMed's Price Target to AU$40.55 from AU$40.54, Keeps at Overweight

MT Newswires Live

ResMed Bulls See Potential for 4Q Margin Beat -- Market Talk

The ultimate Australian stocks to buy and hold for 10+ years

Buy these fantastic ASX 200 blue chips with $10,000

ResMed Inc. Stock Falls Friday, Underperforms Market

How to retire early using ASX shares (even when starting late)

Buy Hold Sell: Quality vs value across 4 ASX pairs

The best ASX shares to buy and forget for 10+ years

Buy Hold Sell: Is there any value left on the ASX? (2 big buys revealed)

Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors

Buy Hold Sell: 5 ASX names with strong balance sheets (and 2 big buys)

ResMed Founder Sells Shares Worth $250,000

MT Newswires Live

ResMed Chief Legal Officer Sells Shares

MT Newswires Live

ResMed Inc. Stock Rises Monday, Outperforms Market

10 Aussie stocks to buy in FY 2026

How to make $5,000 a month in passive income

Managing Earnings Risk in Australia Remains Key -- Market Talk

ResMed Inc. Stock Rises Friday, Outperforms Market

3 ASX Companies That Are Global Leaders

3 Australian shares to buy and hold for the next 5 years

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RMD.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":39.81,"timestamp":1752819120000,"preClose":39.52,"halted":0,"volume":608933,"delay":0,"nameEN":"Resmed DRC","floatShares":145464448,"shares":1463854030,"eps":13.694791091874077,"marketStatus":"Market Closed","change":0.29,"latestTime":"07-18 16:12:00 AEST","open":39.52,"high":39.81,"low":39.37,"amount":24167543,"amplitude":0.011134,"askPrice":39.84,"askSize":133,"bidPrice":39.54,"bidSize":120,"shortable":3,"etf":0,"ttmEps":13.694791091874077,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":39.52,"dividendRate":0.008289,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":0.9947548274754409,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145464448,"roa":"14.01%","roe":"25.81%","lyrEps":0.960656,"volumeRatio":0.9947548274754409,"shares":1463854030,"dividePrice":0.33,"high":39.81,"amplitude":0.011134,"preClose":39.52,"low":39.37,"week52Low":29.85,"pbRate":"6.84","psRate":"7.55","week52High":40.571,"institutionHeld":0,"latestPrice":39.81,"committee":-0.051383,"eps":13.694791091874077,"divideRate":0.008289,"volume":608933,"delay":0,"ttmEps":13.694791091874077,"open":39.52,"prevYearClose":36.609,"prevWeekClose":39.11,"prevMonthClose":39.35,"prevQuarterClose":39.35,"fiveDayClose":39.11,"twentyDayClose":39.16,"sixtyDayClose":33.177},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552529634","title":"Jarden Adjusts ResMed's Price Target to AU$40.55 from AU$40.54, Keeps at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2552529634","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552529634?lang=en_us&edition=fundamental","pubTime":"2025-07-18 14:27","pubTimestamp":1752820054,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) has an average rating of overweight and mean price target of AU$42.85, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2552302064","title":"ResMed Bulls See Potential for 4Q Margin Beat -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2552302064","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552302064?lang=en_us&edition=fundamental","pubTime":"2025-07-18 08:41","pubTimestamp":1752799260,"startTime":"0","endTime":"0","summary":"0041 GMT - ResMed's bulls at Jarden see potential for the breathing-tech maker's 4Q gross margin to surprise to the upside. Analysts Steve Wheen and Tristan Maher forecast on-quarter margin expansion of 20 bps, but tell clients in a note that an even greater improvement is possible. They cite manufacturing and distribution efficiencies, product mix, scale advantages and currency tailwinds as reasons for their optimism. While their 60.1% margin forecast is in line with consensus, they observe that a result of 60.5% would lift EPS by 1.3% relative to their forecasts. Jarden has an overweight rating and A$40.55 target price on the stock, which is down 0.1% at A$39.48. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK7007","BK7501","RMD","BK4548","LU0170899867.USD","BK4082","LU2008162690.USD","LU2177674079.SGD","RMD.AU","BK4567","BK4588","BK4504"],"gpt_icon":0},{"id":"2551140679","title":"The ultimate Australian stocks to buy and hold for 10+ years","url":"https://stock-news.laohu8.com/highlight/detail?id=2551140679","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551140679?lang=en_us&edition=fundamental","pubTime":"2025-07-13 06:34","pubTimestamp":1752359640,"startTime":"0","endTime":"0","summary":"For investors looking to build wealth over the next decade , the key is arguably to focus on high-quality businesses with sustainable competitive advantages and strong growth prospects. But which Australian stocks offer this?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/07/13/the-ultimate-australian-stocks-to-buy-and-hold-for-10-years/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","LU0158827781.USD","BK4534","GMG.AU","BK7067","BK7155","LU2347655156.SGD","XAO.AU","BK7007","LU1668664300.SGD","LU0006306889.USD","LU2023251221.USD","LU2111349929.HKD","LU2271345857.HKD","LU1732800096.USD","LU0106831901.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU0158827948.USD","LU0912757837.SGD","BK7510","BK4504","LU2089284900.SGD","LU1363072403.SGD","RMD.AU","LU0106261372.USD","LU0314104364.USD","LU1548497426.USD","LU1162221912.USD","LU0267386448.USD","XJO.AU","XKO.AU","BK4127","LU1989772840.SGD","LU0098860793.USD","LU2028103732.USD","BK4588","IE00BZ1G4Q59.USD","LU0795875169.SGD","LU0795875086.SGD","LU0225283273.USD","LU0320765646.SGD","LU1989772923.USD","LU2357305700.SGD","BK4585","BK4516","LU1074936037.SGD","TLX.AU","LU1720051108.HKD","BK4581"],"gpt_icon":0},{"id":"2551991161","title":"Buy these fantastic ASX 200 blue chips with $10,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2551991161","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551991161?lang=en_us&edition=fundamental","pubTime":"2025-07-13 04:46","pubTimestamp":1752353160,"startTime":"0","endTime":"0","summary":"Having a few blue chip ASX 200 shares in a portfolio can be a great foundation to build from. But which blue chips could be top picks for a $10,000 investment right now?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/07/13/buy-these-fantastic-asx-200-blue-chips-with-10000/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7505","TWE.AU","NST.AU","BK7007","BK7506","BK7501","BK7097","BK7104","RMD.AU"],"gpt_icon":0},{"id":"2550961449","title":"ResMed Inc. Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2550961449","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550961449?lang=en_us&edition=fundamental","pubTime":"2025-07-12 04:55","pubTimestamp":1752267300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  shed 1.42% to $254.40 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.33% to 6,259.75 and Dow Jones Industrial Average  falling 0.63% to 44,371.51.ResMed Inc. closed 3.29% short of its 52-week high of $263.05, which the company reached on January 30th.Trading volume  remained 313,457 below its 50-day average volume of 831,237.Data source: Dow Jones Market Data, FactSet. Data compiled July 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2550994997","title":"How to retire early using ASX shares (even when starting late)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550994997","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550994997?lang=en_us&edition=fundamental","pubTime":"2025-07-12 02:04","pubTimestamp":1752257040,"startTime":"0","endTime":"0","summary":"For many Australians, the idea of early retirement can feel out of reach. But the good news is that even if you're in your 40s or 50s, it is still possible to build a meaningful nest egg using ASX sha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/07/12/how-to-retire-early-using-asx-shares-even-when-starting-late/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7511","MOAT.AU","BK7155","COL.AU","BK7016","BK7007","BK4588","VAS.AU","RMD.AU","BK4585","BK7042","NDQ.AU","BK4550","EDV.AU","BK7040","BK7099","BK7501","GMG.AU","FDN","BK7082","BK7503","BK7510","TLS.AU","WTC.AU"],"gpt_icon":0},{"id":"2550767592","title":"Buy Hold Sell: Quality vs value across 4 ASX pairs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550767592","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550767592?lang=en_us&edition=fundamental","pubTime":"2025-07-11 04:00","pubTimestamp":1752177615,"startTime":"0","endTime":"0","summary":"Investing is rarely black and white, but one of the most enduring debates in equity markets is this: Do you chase the proven performers at a premium, or take a punt on the underpriced underdogs?In today’s episode, we’re putting that question to the test.Joining Livewire's Chris Conwayare two seasoned portfolio managers,Hamish FitzSimonsof AllianceBernstein and Dougal Maple-Brown from Maple-Brown Abbott. Together, they explore some of the ASX’s most closely watched names across key sectors including banks, miners, healthcare, and consumer staples. But there's a twist.For each 'quality' name, Hamish and Dougal will assess the company in classic Buy Hold Sell style. Then, they’ll weigh up a potential 'value' alternative and tell us whether they prefer it.Which ones are still too expensive despite recent drawdowns?And which cheaper stocks have what it takes to close the gap?Please note this episode was filmed on 2 July 2025.Chris Conway: First up, Commonwealth Bank, Hamish, I'll come to yo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/buy-hold-sell-quality-vs-value-across-4-asx-pairs","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/buy-hold-sell-quality-vs-value-across-4-asx-pairs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["CBA.AU","ANZ.AU","BK7501","BK7095","RMD.AU","BK7067","MTS.AU","COL.AU","FMG.AU","BK7129","BK7082","BK7511","BK7040","BK7135","HOLD","BUY","BK7028","BK7142","BK7007","BK7508","BK7507","CSL.AU","BUY.AU","BHP.AU","WOW.AU"],"gpt_icon":0},{"id":"2550263656","title":"The best ASX shares to buy and forget for 10+ years","url":"https://stock-news.laohu8.com/highlight/detail?id=2550263656","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550263656?lang=en_us&edition=fundamental","pubTime":"2025-07-09 15:36","pubTimestamp":1752046560,"startTime":"0","endTime":"0","summary":"When it comes to building wealth, patience can be your greatest ally. While short-term market moves grab the headlines, the real magic of investing often lies in holding quality businesses for the lon","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/07/09/the-best-asx-shares-to-buy-and-forget-for-10-years/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7090","BK7016","WTC.AU","BK7501","RMD.AU","BK7007","TCL.AU","BK7503"],"gpt_icon":0},{"id":"2549376452","title":"Buy Hold Sell: Is there any value left on the ASX? (2 big buys revealed)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549376452","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549376452?lang=en_us&edition=fundamental","pubTime":"2025-07-07 04:00","pubTimestamp":1751832009,"startTime":"0","endTime":"0","summary":"With the ASX hovering near all-time highs, you’d be forgiven for thinking the value train has left the station. But is that really the case?Or are there still pockets of opportunity hiding in plain sight?In this episode of Buy Hold Sell, we dig into whether there’s any genuine value left in the market, and where two leading investors are finding it.Dougal Maple-Brown from Maple-Brown Abbott and Hamish FitzSimons from AllianceBernstein share their philosophies, the must-have traits of a value stock, and what sectors they’re eyeing right now.Plus, they name one stock to avoid - and one they’re buying.Please note this episode was filmed on 2 July 2025.Dougal Maple-Brown:Totally agree with Hamish. I’d take it one step further and say it’s really about interest rates. Since the GFC, rates globally have gone from the top left of your screen to the bottom right – effectively from modest levels to almost nothing. That’s been tou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/buy-hold-sell-is-there-any-value-left-on-the-asx-2-big-buys-revealed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/buy-hold-sell-is-there-any-value-left-on-the-asx-2-big-buys-revealed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["EDV.AU","BHP.AU","XKO.AU","CSL.AU","XJO.AU","RIO.AU","BK7104","BK7507","SHL.AU","BK7508","RRL.AU","BK7124","BK7007","NEC.AU","BK7067","BK7040","IPH.AU","ANZ.AU","XAO.AU","BK7050","BK7501","BK7095","BK7511","RMD.AU","BK7135","BK7052"],"gpt_icon":0},{"id":"2549716323","title":"Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2549716323","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549716323?lang=en_us&edition=fundamental","pubTime":"2025-07-06 08:00","pubTimestamp":1751760000,"startTime":"0","endTime":"0","summary":"ASX200 healthcare shares led themarket sectorslast week with a 3.28% increase over the five trading days. The S&P/ASX 200 Index had a great start to the new financial year, rising 1.04% over the week to finish at 8,603 points. Healthcare was partly propelled by a 9.73% surge for the unstoppable sector darling Pro Medicus Ltd shares. For the first time ever, the Pro Medicus share price cracked the $300 mark last week, closing at $307.89 per share on Friday.  The stock set a new record at $316.47 on Thursday after the company announcedtwo major contracts in the US. Pro Medicus is now one of only two ASX 200 healthcare shares with a share price above $300. The other is Cochlear Ltd  shares.  What does Pro Medicus do?Morgan Stanley and Bell Potter think Pro Medicus shares don't have much more room to grow. Morgan Stanley has an overweight rating and a 12-month price target of $310 on Pro Medicus shares.  Last week, Bell Potter downgraded Pro Medicus from a buy to a hold rating with an impr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/07/06/pro-medicus-shares-surge-10-to-crack-300-as-healthcare-leads-asx-200-sectors-week-27-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7007","LU0314104364.USD","LU0912757837.SGD","BK4534","XJO.AU","BK7067","FPH.AU","BK4504","LU0225283273.USD","BK7113","LU0158827948.USD","LU1732800096.USD","RMD.AU","BK7501","BK7103","LU0006306889.USD","CU6.AU","LU0267386448.USD","LU2133065610.SGD","LU2271345857.HKD","SHL.AU","LU0795875169.SGD","LU0971096721.USD","BK7094","BK4516","RHC.AU","LU1363072403.SGD","BK4588","LU2347655156.SGD","LU2089283258.USD","LU1668664300.SGD","COH.AU","LU2111349929.HKD","BK7096","LU0106261372.USD","LU1989772840.SGD","BK4127","PME.AU","CSL.AU","BK4581","LU2089284900.SGD","LU1720051017.SGD","LU0234570918.USD","LU0795875086.SGD","LU1989772923.USD","BK7511","BK4585","SIG.AU","BK7508","LU1720051108.HKD"],"gpt_icon":0},{"id":"2548387388","title":"Buy Hold Sell: 5 ASX names with strong balance sheets (and 2 big buys)","url":"https://stock-news.laohu8.com/highlight/detail?id=2548387388","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548387388?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:00","pubTimestamp":1751572807,"startTime":"0","endTime":"0","summary":"No matter which factor you like, clear-cut winners are hard to find. Why?Because quality is rarely cheap and value can be anything but. So in this episode, we're going to keep it simple by running the ruler over five ASX names with strong balance sheets.These are companies that boast robust financial foundations: low debt, consistent cash flows, and disciplined capital management.Such businesses typically not only weather economic storms but often emerge stronger on the other side. But that does not mean they are automatic 'buys' if the valuation doesn't stack up.Applying their respective lenses are Dougal Maple-Brown from Maple-Brown Abbott, and Hamish FitzSimons from AllianceBernstein.For good measure, they also share one ASX name that they like right now.Please note this episode was filmed on 2 July 2025.Hamish FitzSimons : Well, I think the Coles people would differ with you. I'll let you have that argument with them. No, look, we have that as a buy. Woollies, it's come back a fair","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/buy-hold-sell-5-asx-names-with-strong-balance-sheets-and-2-big-buys","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/buy-hold-sell-5-asx-names-with-strong-balance-sheets-and-2-big-buys","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7501","WES.AU","BK7142","BK7097","BK7007","BK7002","BK7040","BUY.AU","BK7503","BK7041","COL.AU","BK7082","RMD.AU","BK7078","BK7064","BXB.AU","REA.AU","WOW.AU","BUY","BK7511","ALL.AU","BK7153","TWE.AU","BK7505","HOLD"],"gpt_icon":0},{"id":"2548639841","title":"ResMed Founder Sells Shares Worth $250,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2548639841","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548639841?lang=en_us&edition=fundamental","pubTime":"2025-07-03 08:40","pubTimestamp":1751503238,"startTime":"0","endTime":"0","summary":"ResMed's  founder, Peter Farrel, sold 945 shares on the New York Stock Exchange for $250,000 in total, according to a Thursday filing with the Australian bourse.Following the sale of shares, Farrel owns about 146.9 million shares in the company, per the filing.The company's Australian shares slipped almost 1% in recent Thursday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RMD.AU","RMD","BK4588","LU2177674079.SGD","BK4504","LU0170899867.USD","BK7501","BK4082","BK4548","LU2008162690.USD","XKO.AU","BK4585","BK4567","XAO.AU","XJO.AU","BK7007"],"gpt_icon":0},{"id":"2548835245","title":"ResMed Chief Legal Officer Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2548835245","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548835245?lang=en_us&edition=fundamental","pubTime":"2025-07-02 07:47","pubTimestamp":1751413676,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) Chief Legal Officer Michael Rider sold 66 shares on the New York Stock Exchange for $16,961 in total, according to a Wednesday filing with the Australian bourse.Following the sale of shares, Rider owns 146.6 million shares in the company, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4082","BK4504","LU2177674079.SGD","LU0170899867.USD","BK4548","RMD.AU","XAO.AU","BK4585","BK4567","RMD","BK7501","XKO.AU","BK7007","XJO.AU","LU2008162690.USD"],"gpt_icon":0},{"id":"2548489940","title":"ResMed Inc. Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2548489940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548489940?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:53","pubTimestamp":1751316780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 1.11% to $258.00 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.52% to 6,204.95 and the Dow Jones Industrial Average  rising 0.63% to 44,094.77.The stock's rise snapped a two-day losing streak.ResMed Inc. closed 1.92% short of its 52-week high of $263.05, which the company reached on January 30th.Trading volume  eclipsed its 50-day average volume of 930,424.Data source: Dow Jones Market Data, FactSet. Data compiled June 30, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2546677843","title":"10 Aussie stocks to buy in FY 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2546677843","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546677843?lang=en_us&edition=fundamental","pubTime":"2025-06-28 08:07","pubTimestamp":1751069220,"startTime":"0","endTime":"0","summary":"With the new financial year upon us, investors may be wondering where to find the best opportunities on the ASX. Let's take a look at 10 Aussie stocks that analysts are positive on as we head into FY ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/06/28/10-aussie-stocks-to-buy-in-fy-2026/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["AZJ.AU","BK7067","TPW.AU","LU0106831901.USD","LU0971096721.USD","LU2271345857.HKD","LU0158827781.USD","LU1732800096.USD","BK7049","BK7504","IE00BKVL7J92.USD","BK4127","LU0234570918.USD","LU1720051108.HKD","NXT.AU","LU0225283273.USD","MP1.AU","LU0098860793.USD","LU2023251221.USD","BK4588","LU1720051017.SGD","GMG.AU","LU0158827948.USD","BK7508","LU1989772923.USD","LU2111349929.HKD","LU1989772840.SGD","RMD.AU","BK7046","BK7511","LU1363072403.SGD","COH.AU","MQG.AU","LU2357305700.SGD","LU1162221912.USD","LU2089284900.SGD","BK7043","LU1668664300.SGD","BK7140","LU0106261372.USD","CSL.AU","LU1732799900.SGD","BK7007","BK7507","BK7510","ALL.AU","LU0795875086.SGD","PLS.AU","LU0267386448.USD","BK7503"],"gpt_icon":0},{"id":"2546781787","title":"How to make $5,000 a month in passive income","url":"https://stock-news.laohu8.com/highlight/detail?id=2546781787","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546781787?lang=en_us&edition=fundamental","pubTime":"2025-06-28 04:35","pubTimestamp":1751056500,"startTime":"0","endTime":"0","summary":"Building a $5,000 a month passive income stream is a dream I'm sure many people have. But how could you turn this dream into a reality?$2,000 a month would get you there in a touch over 18 years, all else equal. This will take time, but once you are there, it's time to move to the next step. Step 3: transition to income Once you've built your nest egg, you can gradually pivot toward reliable dividend payers and income-focused ETFs. By allocating your $1.2 million into a portfolio yielding 5%, you'd be earning approximately $5,000 a month — without needing to sell your capital. Foolish takeaway Making $5,000 a month in passive income is a marathon, not a sprint. But it's a race that many investors can finish — with the right mindset, strategy, and time horizon. Start by focusing on growth. Keep your contributions regular. And when the time is right, shift gears toward income. With patience and discipline, you can turn your portfolio into a reliable second income stream — and live the ki","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/06/28/how-to-make-5000-a-month-in-passive-income/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7510","BK7067","BK7007","BK7155","BK7099","BK7501","GMG.AU","TLX.AU","RMD.AU"],"gpt_icon":0},{"id":"2545842964","title":"Managing Earnings Risk in Australia Remains Key -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2545842964","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545842964?lang=en_us&edition=fundamental","pubTime":"2025-06-24 08:27","pubTimestamp":1750724820,"startTime":"0","endTime":"0","summary":"0027 GMT - Investors in Australian equities need to continue navigating heightened earnings risks, Macquarie says. The broader market carries an elevated valuation that has been supported by flows. Macquarie favors stocks that have upgraded 2026 EPS views and have more positive momentum. These include QBE Insurance, GPT, ResMed, and Metcash. Macquarie urges investors to limit exposure to stocks such as Reliance Worldwide and Orora that recently downgraded their outlook and have weaker momentum. The benchmark S&P/ASX 200 index is up 0.9% today. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","MTS.AU","QBIEY","RMD","QBE.AU","RWC.AU","GPT.AU","ORA.AU"],"gpt_icon":0},{"id":"2545108494","title":"ResMed Inc. Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2545108494","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545108494?lang=en_us&edition=fundamental","pubTime":"2025-06-21 04:55","pubTimestamp":1750452900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 1.12% to $253.68 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.08% to 42,206.82 and the S&P 500 Index  falling 0.22% to 5,967.84.This was the stock's second consecutive day of gains.ResMed Inc. closed 3.56% below its 52-week high of $263.05, which the company reached on January 30th.Trading volume  remained 50,913 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 20, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2544116127","title":"3 ASX Companies That Are Global Leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2544116127","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544116127?lang=en_us&edition=fundamental","pubTime":"2025-06-20 13:38","pubTimestamp":1750397890,"startTime":"0","endTime":"0","summary":"There's more to the ASX than just banks and miners.  And some companies are having a big impact on a global scale. Here, we look at three ASX healthcare giants that are global leaders in terms of both","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/06/20/3-asx-companies-that-are-global-leaders/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","CSL.AU","BK7007","BK7511","BK7501","RMD.AU","COH.AU","BK7067"],"gpt_icon":0},{"id":"2544418323","title":"3 Australian shares to buy and hold for the next 5 years","url":"https://stock-news.laohu8.com/highlight/detail?id=2544418323","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544418323?lang=en_us&edition=fundamental","pubTime":"2025-06-18 06:11","pubTimestamp":1750198284,"startTime":"0","endTime":"0","summary":"Investing with a five-year view requires more than just picking what's hot today. It is about identifying Australian shares with sustainable competitive advantages, scalable business models, and stron","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/06/18/3-australian-shares-to-buy-and-hold-for-the-next-5-years/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["TLX.AU","XAO.AU","RMD.AU","XJO.AU","XKO.AU","BK7070","WEB.AU","BK7501","BK7007","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-08","defaultRemindTime":1746576000000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746540000000,"payDate":"2025-06-12"},{"date":"2025-02-12","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-01-31","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-13","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-13","currency":"USD","dateTimestamp":1739278800000,"payDate":"2025-03-20"},{"date":"2024-11-06","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-10-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-11-07","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-07","currency":"USD","dateTimestamp":1730811600000,"payDate":"2024-12-12"},{"date":"2024-08-14","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-08-02","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-08-15","defaultRemindTime":1723593600000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-19","payableDate":"2024-08-15","currency":"USD","dateTimestamp":1723557600000,"payDate":"2024-09-19"},{"date":"2024-05-08","symbol":"RMD.AU","amount":0.048,"announcedDate":"2024-04-26","type":"dividend","market":"AU","newRecordDate":"2024-05-09","defaultRemindTime":1715126400000,"name":"Resmed DRC","recordDate":"2024-06-13","payableDate":"2024-05-09","currency":"USD","dateTimestamp":1715090400000,"payDate":"2024-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}]}}